Chapter 9: Hepatic Digestic Pathology Flashcards
Most frequent symptoms of oesophageal disorders?
Dysphagia, regurgitations, halitosis, sialorrhea
Management of the patient with oesophageal alterations:
Prescription of small capsule meds or envelopes
Avoid anaesthetic intake to avoid feeling of not being able to swallow
Management of the patient with stomach and intestine disorders:
• Avoid intake of aspirin and anti-inflammatory drugs (steroids). If necessary with food and stomach protector such as omeprazole. 1 pill every 24 hours.
• Avoid prolonged treatments with antibiotics because of the drop of intestinal flora. NB: nowadays we add probiotics with ATB.
Hepatitis A:
- Incubation period: 2-6 weeks (15-45 days).
Transmission: HA in infected excreta. Oral-fecal transmission. Healing in 2-3-6 months.
Fulminant hepatitis (1-5%) liver transplantation.
Symptoms and signs (> adult frequency):
• Asymptomatic.
• Hepatomegaly.
• Tiredness, nausea, fever, anorexia, abdominal pain, diarrhoea, jaundice, choluria, acholia.
Diagnosis of hepatitis A:
• Clinical history.
• Antibodies anti VHA (IgM- IgG).
IgM persists for 2-4 months.
IgG persists as an indicator for years. Prevention:
• Vaccination.
• Personal and environmental hygiene.
Hepatitis B:
- Incubation period: 6 weeks - 6 months.
- Transmission mechanisms:
• Parenteral: through syringes and infected blood products.
• Sexual.
• Perinatal or vertical: from mother to child at birth.
• Horizontal: through contact with infected people. The virus can remain stable for up to 7 days
on different surfaces of the environment.
Transmission through contaminated objects (toothbrushes, bottles, toys, cutlery, or sanitary equipment), by contact with membranes, mucous membranes, or open wounds.
Hepatitis C:
- Incubation period: 2-12 months. (Longest incubation period).
- ## -
- -
Acute hepatitis: 3-6 months to a year, most frequently asymptomatic. • At times: fatigue myalgias, nausea, vomiting, infrequent jaundice.
• Spontaneous healing (approx: 20%).
Chronic hepatitis: 50-80%,can be extended 10, 20, 30 years with no more symptoms than the
alteration of some liver markers. • Evolution:
Fibrosis.
Cirrhosis.
Hepatocellular carcinoma.
Ways of transmission:
• Intravenous drugs (40%).
• Inhalation cocaine/heroin.
• Tattoos, piercings.
• No apparent cause (40%). • Sexual contact (6%).
• Family contact (3%).
• Occupational contact (2%).
VHC can be detected in a contaminated gauze by the infected patient’s blood for up to 24 hours!!!!
Management of patient with hepatitis:
Avoid potential transmission of the infections agent (barrier, sterilisation, and disinfection methods).
• Preventing the risk of bleeding: coagulation tests.
• Prescription medication:
Avoid drugs of hepatic metabolism. Adjust dose.
Alcoholics (non-alcoholic drugs and avoid interactions).
• In the acute phase, only EMERGENCY treatments.
• In chronic patients, investigate associated
pathologies.
• Prevention of hemorrhage.
• Control measures: universal or standard
precautions;
Vaccination: all healthcare personnel should be vaccinated against HB as an effective measure to prevent the transmission of the disease.
In the market we have 2 vaccines (Engerix B and Recombivax HB): MI in deltoids (first dose , one month and six months after).
• One month after completing all 3 doses, a check will be made to check to see if the antibody has reached its correct level (> 10 IU/ML- ELISA).